121 related articles for article (PubMed ID: 31926781)
1. Corrigendum to "MicroRNA-21 suppresses PTEN and hSulf-1 expression and promotes hepatocellular carcinoma progression through AKT/ERK pathways" [Canc. Lett. 337 (2013) 226-236].
Bao L; Yan Y; Xu C; Ji W; Shen S; Xu G; Zeng Y; Sun B; Qian H; Chen L; Wu M; Chen J; Su C
Cancer Lett; 2020 Mar; 473():198-199. PubMed ID: 31926781
[No Abstract] [Full Text] [Related]
2. Corrigendum to "MicroRNA-21 suppresses PTEN and hSulf-1 expression and promotes hepatocellular carcinoma progression through AKT/ERK pathways" [Cancer Letters 337 (2013) 226-236].
Bao L; Yan Y; Xu C; Ji W; Shen S; Xu G; Zeng Y; Sun B; Qian H; Chen L; Wu M; Chen J; Su C
Cancer Lett; 2020 Jun; 480():49-50. PubMed ID: 31982228
[No Abstract] [Full Text] [Related]
3. MicroRNA-21 suppresses PTEN and hSulf-1 expression and promotes hepatocellular carcinoma progression through AKT/ERK pathways.
Bao L; Yan Y; Xu C; Ji W; Shen S; Xu G; Zeng Y; Sun B; Qian H; Chen L; Wu M; Su C; Chen J
Cancer Lett; 2013 Sep; 337(2):226-36. PubMed ID: 23684551
[TBL] [Abstract][Full Text] [Related]
4. Corrigendum to "cPLA2α activates PI3K/AKT and inhibits Smad2/3 during epithelial-mesenchymal transition of hepatocellular carcinoma cells" [Canc. Lett. 403 (2017) 260-270].
Fu H; He Y; Qi L; Chen L; Luo Y; Chen L; Li Y; Zhang N; Guo H
Cancer Lett; 2021 Feb; 498():240-241. PubMed ID: 33221059
[No Abstract] [Full Text] [Related]
5. Corrigendum to "Long non-coding RNA Unigene 56159 promotes epithelial-mesenchymal transition by acting as a ceRNA of miR-140-5p in hepatocellular carcinoma cells" [Canc. Lett. 382 (2016) 166-175].
Lv J; Fan HX; Zhao XP; Lv P; Fan JY; Zhang Y; Liu M; Tang H
Cancer Lett; 2020 Mar; 472():181-182. PubMed ID: 31879079
[No Abstract] [Full Text] [Related]
6. Corrigendum to "NRF2/SHH signaling cascade promotes tumor-initiating cell lineage and drug resistance in hepatocellular carcinoma" [Canc. Lett. 476 (2020) 48-56].
Leung HW; Lau EYT; Leung CON; Lei MML; Mok EHK; Ma VWS; Cho WCS; Ng IOL; Yun JP; Cai SH; Yu HJ; Ma S; Lee TKW
Cancer Lett; 2021 Feb; 499():2. PubMed ID: 32563702
[No Abstract] [Full Text] [Related]
7. Corrigendum to "Circadian clock gene NPAS2 promotes reprogramming of glucose metabolism in hepatocellular carcinoma cells" [Canc. Lett. 469 (2020) 498-509].
Yuan P; Yang T; Mu J; Zhao J; Yang Y; Yan Z; Hou Y; Chen C; Xing J; Zhang H; Li J
Cancer Lett; 2021 Nov; 521():322-323. PubMed ID: 34521548
[No Abstract] [Full Text] [Related]
8. Corrigendum to "AGBL2 promotes cancer cell growth through IRGM-regulated autophagy and enhanced Aurora A activity in hepatocellular carcinoma" [Canc. Lett. 414 (2018) 71-80].
Wang LL; Jin XH; Cai MY; Li HG; Chen JW; Wang FW; Wang CY; Hu WW; Liu F; Xie D
Cancer Lett; 2022 Jul; 539():215700. PubMed ID: 35525812
[No Abstract] [Full Text] [Related]
9. Corrigendum to "LncRNA n335586/miR-924/CKMT1A axis contributes to cell migration and invasion in hepatocellular carcinoma cells" [Canc. Lett. 429 (2018) 89-99].
Fan H; Lv P; Mu T; Zhao X; Liu Y; Feng Y; Lv J; Liu M; Tang H
Cancer Lett; 2020 Dec; 494():84-87. PubMed ID: 32911100
[No Abstract] [Full Text] [Related]
10. microRNA-19a-3p promotes tumor metastasis and chemoresistance through the PTEN/Akt pathway in hepatocellular carcinoma.
Jiang XM; Yu XN; Liu TT; Zhu HR; Shi X; Bilegsaikhan E; Guo HY; Song GQ; Weng SQ; Huang XX; Dong L; Janssen HLA; Shen XZ; Zhu JM
Biomed Pharmacother; 2018 Sep; 105():1147-1154. PubMed ID: 30021351
[TBL] [Abstract][Full Text] [Related]
11. Corrigendum to "miR-371-5p down-regulates pre mRNA processing factor 4 homolog B (PRPF4B) and facilitates the G1/S transition in human hepatocellular carcinoma" [Canc. Lett. 335 (2013) 351-360].
Liu RY; Diao CF; Zhang Y; Wu N; Wan HY; Nong XY; Liu M; Tang H
Cancer Lett; 2021 May; 505():87-90. PubMed ID: 33685752
[No Abstract] [Full Text] [Related]
12. Corrigendum to "Rab8A promotes breast cancer progression by increasing surface expression of Tropomyosin-related kinase B" [Canc. Lett. 535 (2022) 215629].
Liu Y; Zhang Z; Gao X; Ma Q; Yu Z; Huang S
Cancer Lett; 2022 Jul; 539():215701. PubMed ID: 35527117
[No Abstract] [Full Text] [Related]
13. Corrigendum to "MiR-590-5p, a density-sensitive microRNA, inhibits tumorigenesis by targeting YAP1 in colorectal cancer", [Canc. Lett. 399 (2017) 53-63].
Ou C; Sun Z; Li X; Li X; Ren W; Qin Z; Zhang X; Yuan W; Wang J; Yu W; Zhang S; Peng Q; Yan Q; Xiong W; Li G; Ma J
Cancer Lett; 2018 Apr; 420():260. PubMed ID: 29429755
[No Abstract] [Full Text] [Related]
14. Corrigendum to "TGF-β1 targets a microRNA network that regulates cellular adhesion and migration in renal cancer" [Canc. Lett. 412 (2018) 155-169].
Bogusławska J; Rodzik K; Popławski P; Kędzierska H; Rybicka B; Sokół E; Tański Z; Piekiełko-Witkowska A
Cancer Lett; 2020 Jun; 480():52-55. PubMed ID: 32005526
[No Abstract] [Full Text] [Related]
15. Corrigendum to "Voltage-gated sodium channel Nav1.5 promotes tumor progression and enhances chemosensitivity to 5-fluorouracil in colorectal cancer" [Canc. Lett. 500 (2021) 119-131].
Sui Q; Peng J; Han K; Lin J; Zhang R; Ou Q; Qin J; Deng Y; Zhou W; Kong L; Tang J; Xiao B; Li Y; Yu L; Fang Y; Ding PR; Pan Z
Cancer Lett; 2021 Sep; 516():57-60. PubMed ID: 34091433
[No Abstract] [Full Text] [Related]
16. Corrigendum to "Forkhead box D1 promotes EMT and chemoresistance by upregulating lncRNA CYTOR in oral squamous cell carcinoma" [Canc. Lett. 503 (2021) 43-53].
Chen S; Yang M; Wang C; Ouyang Y; Chen X; Bai J; Hu Y; Song M; Zhang S; Zhang Q
Cancer Lett; 2022 Jul; 537():215688. PubMed ID: 35459579
[No Abstract] [Full Text] [Related]
17. Corrigendum to "SUMOylation of SYNJ2BP-COX16 promotes breast cancer progression through DRP1-mediated mitochondrial fission" [Canc. Lett. 547 (2022) 215871].
Wang M; Wei R; Li G; Bi HL; Jia Z; Zhang M; Pang M; Li X; Ma L; Tang Y
Cancer Lett; 2022 Nov; 549():215923. PubMed ID: 36166936
[No Abstract] [Full Text] [Related]
18. Corrigendum to "FAT1 prevents epithelial mesenchymal transition (EMT) via MAPK/ERK signaling pathway in esophageal squamous cell cancer" [Canc. Lett. 397 (2017) 83-93].
Hu X; Zhai Y; Kong P; Cui H; Yan T; Yang J; Qian Y; Ma Y; Wang F; Li H; Cheng C; Zhang L; Jia Z; Li Y; Yang B; Xu E; Wang J; Yang J; Bi Y; Chang L; Wang Y; Zhang Y; Song B; Li G; Shi R; Liu J; Zhang M; Cheng X; Cui Y
Cancer Lett; 2020 Dec; 494():1-2. PubMed ID: 32818769
[No Abstract] [Full Text] [Related]
19. Retraction notice to "EMP3, which is regulated by miR-663a, suppresses gallbladder cancer progression via interference with the MAPK/ERK pathway" [Canc. Lett. 430 (2018) 97-108].
Ma Q; Zhang Y; Liang H; Zhang F; Liu F; Chen S; Hu Y; Jiang L; Hao Y; Li M; Liu Y
Cancer Lett; 2022 Nov; 549():215932. PubMed ID: 36216653
[No Abstract] [Full Text] [Related]
20. Corrigendum to "Long non-coding RNA LOC389641 promotes progression of pancreatic ductal adenocarcinoma and increases cell invasion by regulating E-cadherin in a TNFRSF10A-related manner" [Canc. Lett. 371 (2016) 354-365].
Zheng S; Chen H; Wang Y; Gao W; Fu Z; Zhou Q; Jiang Y; Lin Q; Tan L; Ye H; Zhao X; Luo Y; Li G; Ye L; Liu Y; Li W; Li Z; Chen R
Cancer Lett; 2022 Oct; 545():215859. PubMed ID: 35940956
[No Abstract] [Full Text] [Related]
[Next] [New Search]
